Professor of Internal Medicine
IRB Vice Chair
Associate Residency Program Director
[email protected]
Available to mentor
Kevin R Flaherty
Professor
-
Kim JS, Ma S-F, Ma JZ, Huang Y, Bonham CA, Oldham JM, Adegunsoye A, Strek ME, Flaherty KR, Strickland E, Udofia I, Mooney JJ, Ghosh S, Maddipati K, Noth I. Chest, 2024 Mar; 165 (3): 621 - 631.Journal ArticleAssociations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis.
DOI:10.1016/j.chest.2023.09.035 PMID: 37866772 -
Oh AS, Lynch DA, Swigris JJ, Baraghoshi D, Dyer DS, Hale VA, Koelsch TL, Marrocchio C, Parker KN, Teague SD, Flaherty KR, Humphries SM. Ann Am Thorac Soc, 2024 Feb; 21 (2): 218 - 227.Journal ArticleDeep Learning-based Fibrosis Extent on Computed Tomography Predicts Outcome of Fibrosing Interstitial Lung Disease Independent of Visually Assessed Computed Tomography Pattern.
DOI:10.1513/AnnalsATS.202301-084OC PMID: 37696027 -
Wijsenbeek M, Swigris JJ, Inoue Y, Kreuter M, Maher TM, Suda T, Baldwin M, Mueller H, Rohr KB, Flaherty KR, INBUILD Trial Investigators . Eur Respir J, 2024 Feb; 63 (2):Journal ArticleEffects of nintedanib on symptoms in patients with progressive pulmonary fibrosis.
DOI:10.1183/13993003.00752-2023 PMID: 38135442 -
Montesi SB, Gomez CR, Beers M, Brown R, Chattopadhyay I, Flaherty KR, Garcia CK, Gomperts B, Hariri LP, Hogaboam CM, Jenkins RG, Kaminski N, Kim GHJ, Königshoff M, Kolb M, Kotton DN, Kropski JA, Lasky J, Magin CM, Maher TM, McCormick M, Moore BB, Nickerson-Nutter C, Oldham J, Podolanczuk AJ, Raghu G, Rosas I, Rowe SM, Schmidt WT, Schwartz D, Shore JE, Spino C, Craig JM, Martinez FJ. Am J Respir Crit Care Med, 2024 Feb 15; 209 (4): 362 - 373.Journal ArticlePulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.
DOI:10.1164/rccm.202307-1154WS PMID: 38113442 -
King CS, Ignacio RV, Khangoora V, Nyquist A, Singhal A, Thomas C, Cantres OF, Aryal S, Shlobin OA, Flaherty K, Lasky J, Nathan SD. Am J Respir Crit Care Med, 2024 Jan 18;Journal ArticleHospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry.
DOI:10.1164/rccm.202309-1708OC PMID: 38236191 -
Humphries SM, Thieke D, Baraghoshi D, Strand MJ, Swigris JJ, Chae KJ, Hwang HJ, Oh AS, Flaherty KR, Adegunsoye A, Jablonski R, Lee CT, Husain AN, Chung JH, Strek ME, Lynch DA. Am J Respir Crit Care Med, 2024 Jan 11;Journal ArticleDeep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes.
DOI:10.1164/rccm.202307-1191OC PMID: 38207093 -
Yun JH, Khan MAW, Ghosh A, Hobbs BD, Castaldi PJ, Hersh CP, Miller PG, Cool CD, Sciurba F, Barwick L, Limper AH, Flaherty K, Criner GJ, Brown K, Wise R, Martinez F, Silverman EK, DeMeo D, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium , Cho MH, Bick AG. Am J Respir Crit Care Med, 2023 Dec 1; 208 (11): 1196 - 1205.Journal ArticleClonal Somatic Mutations in Chronic Lung Diseases Are Associated with Reduced Lung Function.
DOI:10.1164/rccm.202303-0395OC PMID: 37788444 -
Kolb M, Flaherty KR, Silva RS, Prasse A, Vancheri C, Mueller H, Sroka-Saidi K, Wells AU, INBUILD trial investigators . Adv Ther, 2023 Dec; 40 (12): 5536 - 5546.Journal ArticleEffect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics.
DOI:10.1007/s12325-023-02668-x PMID: 37751022